Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cytovance® Biologics announced the appointment of Jesse McCool, Ph.D. as Chief Technology Officer.
read more
Cobra Biologics and Symbiosis Pharmaceutical Services announced the successful completion of their collaboration to develop synergistic and world leading capabilities.
read more
The FDA has issued warning letters to three repackers of API for significant violations of current good manufacturing practice (CGMP) requirements.
read more
Pii announced the expansion of its commercial team with the additions of Wayne Ideus, Wayne Grellner and Ryan McFarlane.
read more
Abveris and Harbour Antibodies H2L2 BV announced a partnership to offer fully-human antibody discovery service that combines Abveris’ antibody discovery services with the Harbour H2L2 human transgenic mouse platform.
read more
Fresenius Kabi is voluntarily recalling two lots of Fluorouracil Injection, USP 5g/100mL (50mg/mL), 100mL fill in 100mL vials, to the user level due to the potential for glass particulate.
read more
Nosopharm and Evotec announced their partnership aimed at advancing NOSO-502, to the clinical stage, as well as developing a second-generation Odilorhabdin drug candidate.
read more
Luminex announced the company submitted the ARIES® MRSA Assay to the U.S. Food and Drug Administration (FDA) for clearance.
read more
Dr. Reddy’s announced the launch of Carboprost Tromethamine Injection USP Single-dose Vial, a therapeutic equivalent generic version of Hemabate®, 250 mcg/mL, approved by the FDA.
read more
ALTEN Calsoft Labs has launched – "BioPharma Ledger," a Blockchain clinical trial platform.
read more
Onco360® announced it has been selected as a specialty pharmacy network partner for Karyopharm’s new product XPOVIO™ (selinexor).
read more
The Wasdell Group announced its new state-of-the-art facility in Dundalk, Ireland has received its MIA from the Health Products Regulatory Authority (HPRA).
read more
ZYUS Life Sciences announced it has entered into a definitive agreement to acquire the Kentucky-based healthcare technology company Revon Systems in a share for share transaction.
read more
Crescita has received the second installment of the up-front payment related to the out-licensing of Pliaglis in Italy, France, Spain and Portugal, from its partner, Cantabria Labs.
read more
BioInvent announced it will receive a $0.5 million milestone payment related to the acceptance by the FDA of the IND application for TAK-169, a first-in-class CD38-targeted fusion protein.
read more